Celltrion Pharm, Inc. (KOSDAQ:068760)
52,500
-100 (-0.19%)
Mar 26, 2025, 3:30 PM KST
Celltrion Pharm Company Description
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs.
It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.
Celltrion Pharm, Inc.
Country | South Korea |
Founded | 1976 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 328 |
CEO | Jung-su Seo |
Contact Details
Address: 82, 2sandan-ro Cheongju-si South Korea | |
Phone | 82 4 3717 7000 |
Website | celltrionph.com |
Stock Details
Ticker Symbol | 068760 |
Exchange | KOSDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | KRW |
ISIN Number | KR7068760008 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Jung-su Seo | Chief Executive Officer |